Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.712 USD | -1.17% | -0.13% | -12.10% |
Business Summary
Number of employees: 165
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 14 | 100.0 % | 20 | 100.0 % | +41.27% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 14 | 100.0 % | 20 | 100.0 % | +41.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Klaus Orlinger
CTO | Chief Tech/Sci/R&D Officer | 46 | 12-01-31 |
Roman Necina
COO | Chief Operating Officer | 56 | 19-10-31 |
Tony Melckenbeek
PRN | Corporate Officer/Principal | - | - |
Daniel Courtney
SEC | Corporate Secretary | - | 17-12-31 |
Victor Paulus
LAW | General Counsel | - | 18-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Chairman | 63 | 17-09-30 | |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Julie O'Neill
BRD | Director/Board Member | 58 | 18-10-31 |
Malte Peters
BRD | Director/Board Member | 61 | 22-12-31 |
Mary Coelho
BRD | Director/Board Member | 62 | 23-04-02 |
David Kaufman
BRD | Director/Board Member | 51 | 19-04-24 |
Timothy Reilly
BRD | Director/Board Member | 50 | 22-04-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 2,399,517 | 0 | 0 | 78.46 % |
Stock B | 1 | 96,550,590 | 77,635,470 ( 80.41 %) | 0 |
Company contact information
HOOKIPA Pharma, Inc.
350 Fifth Avenue 72nd floor, Suite 7240
10118, New York
+
http://www.hookipapharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.10% | 71.28M | |
+33.46% | 701B | |
+26.24% | 571B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-3.61% | 157B |
- Stock
- Equities
- Stock HOOKIPA Pharma Inc. - Nasdaq
- Company HOOKIPA Pharma Inc.